Objectives-To examine the effect of occupational exposure to cyclohexane on the peripheral nervous system. Methods-A nerve conduction study was performed on 18 workers exposed to cyclohexane in a luggage factory and on age and sex matched occupationally unexposed controls. 12 workers had been exposed to n-hexane (median 2-8 years) before the start of exposure to cyclohexane. To confirm the effect of exposure, a follow up study was performed on nine workers one year after the first study. The mean exposure to cyclohexane was 1 2 years in the first study. A symptom survey was performed. The exposure was measured by air sampling of the breathing zone of each worker. The urinary metabolite cyclohexanol was also monitored. Results-The concentration of airborne cyclohexane ranged from 5 to 211 ppm. The urinary concentration of cyclohexanol ranged from 0-12 to 1 51 mg/I. There was a strong correlation between the cyclohexane exposure in personal air and urinary cyclohexanol. No differences were found in nerve conduction velocities (NCV) between workers exposed to cylohexane and age and sex matched controls. The results of the follow up study showed significant improvements in peroneal motor NCV (P < 0.01) and sural sensory NCV (P < 005) and in ulnar motor distal latency (MDL, P < 005) and peroneal MDL (P < 005) compared with the first study. Although the past n-hexane exposure affected the first neurophysiological study, the effect had disappeared in the second study, one year later. Conclusion-Occupational exposure to the concentrations of cyclohexane experianced in this study had no adverse effects on the peripheral nervous system. (Occup Environ Med 1996;53:174-179) 
Objectives-To examine the effect of occupational exposure to cyclohexane on the peripheral nervous system. Methods-A nerve conduction study was performed on 18 workers exposed to cyclohexane in a luggage factory and on age and sex matched occupationally unexposed controls. 12 workers had been exposed to n-hexane (median 2-8 years) before the start of exposure to cyclohexane. To confirm the effect of exposure, a follow up study was performed on nine workers one year after the first study. The mean exposure to cyclohexane was 1 2 years in the first study. A symptom survey was performed. The exposure was measured by air sampling of the breathing zone of each worker. The urinary metabolite cyclohexanol was also monitored. Results-The concentration of airborne cyclohexane ranged from 5 to 211 ppm. The urinary concentration of cyclohexanol ranged from 0-12 to 1 51 mg/I. There was a strong correlation between the cyclohexane exposure in personal air and urinary cyclohexanol. No differences were found in nerve conduction velocities (NCV) between workers exposed to cylohexane and age and sex matched controls. The results of the follow up study showed significant improvements in peroneal motor NCV (P < 0.01) and sural sensory NCV (P < 005) and in ulnar motor distal latency (MDL, P < 005) and peroneal MDL (P < 005) compared with the first study. Although the past n-hexane exposure affected the first neurophysiological study, the effect had disappeared in the second study, one year later. Conclusion-Occupational exposure to the concentrations of cyclohexane experianced in this study had no adverse effects on the peripheral nervous system. Cyclohexane has been considered to be a solvent of low toxicity and is recommended as a substitute for other more toxic solvents such as n-hexane and benzene.' However, studies on health effects of cyclohexane and its metabolite, cyclohexanone, are scarce.2A Although it is reported that for cyclohexane the margin between narcosis and death is very narrow and symptomatically barely recognisable,' we considered that a neurophysiological study might detect the neurotoxicity of cyclohexane at a level of exposure too low to cause narcosis or death. Adverse effects on the peripheral nervous system in humans were reported, but this was not the case in rats. 6 However, the exposure was not exclusive in the human studies; therefore, the adverse effect could not necessarily be attributed to cyclohexane.
The primary aim of this study was to examine the neurophysiological effects of occupational exposure to cyclohexane. This is the first study performed in a factory in which workers were exposed almost exclusively to this solvent. To more accurately determine the relation between cyclohexane and neurophysiological effects, a follow up study was performed in some workers.
The factory had used n-hexane in the past and shifted to cyclohexane gradually. Thus, we studied the neurotoxicity of cyclohexane considering the effects of past n-hexane exposure.
Materials and methods
The survey was conducted in a luggage factory. A glue containing 75-6% cyclohexane, 12 0% toluene, and 0 9% n-hexane was used in the factory.7 The workers were selected as follows: (a) cyclohexane was found to be the main solvent to which the workers were exposed, according to the individual exposure data,7 (b) they had been engaged in the current job for more than half a year, and (c) information was available on working conditions, alcohol, tobacco use, and subjective symptoms. Overall, 18 women met the requirements. Their ages ranged from 19 to 56, with a mean (SD) of 24-1 (8-5). They had been engaged in the current job for 04-2 6 years (1 2 (0 6) years) at the time of our first study. On average, they were exposed to cyclohexane vapour for eight hours daily.
Twelve of the exposed workers had been engaged in work with n-hexane for 0 3-20 years (median 2 8 years), and stopped the work 0 7-2 6 years (median 1 3 years) before the first investigation (fig) .
Because of the small sample size of this study, the short duration of exposure to cyclohexane and short duration without exposure to n-hexane, we performed the follow up study one year after the first study to confirm the findings in the first study (fig) . However, nine workers had moved to another department of the same factory or had left the job between The control subjects (18 women) were recruited from among medical students and clerical workers. They were matched to the workers exposed to solvent by sex and age. Their mean (SD) age was 24-7 (8 2). Table 1 shows the characteristics of subjects. Workers exposed to solvent were significantly shorter and lighter than matched controls. The cigarette consumption of workers was higher than that of controls. All of the subjects had no known neurotoxic risks such as diabetes mellitus, alcohol or drug abuse, or neuropathy (including disk herniation).
SYMPTOM SURVEY
The questionnaire used in the symptom survey included questions about subjective symptoms both during work and when not at work in the past six months. In the symptom survey, background variables which could have influenced symptoms and neurophysiological measures, as potential confounders, were investigated (drinking habits, smoking habits, height, weight, years of education, and age). Occupational history was also studied in the survey. Three of 18 controls did not participate in the symptom survey. Among 61 symptoms, 20 general (weight loss, general fatigue, etc) and neurological symptoms were compared. Details of this survey were described previously.
EVALUATION OF EXPOSURE
The airborne cyclohexane of the breathing zone was collected for all workers with a diffusive sampler with activated carbon cloth (KF-1500, Tokyo Company, Osaka, Japan) from the start of the working day to its end,9 over the whole eight hour shift. The urine at the end of the shift was collected and the concentration of urinary cyclohexanol was measured by the enzymatic hydrolysis method. These biological monitorings were performed in both the first and follow up studies. Number ofsubjects, the dates of examinations, and the history of use of solvents in the factory. H= 10 hexane exposure and urinary cyclohexanol measured by the same method used in the present study were available for some workers. To consider the relation between airborne cyclohexane and urinary metabolites, these data were used for analysis. According to the past and present exposure data, the workers were divided into higher (n = 7) and lower (n = 11) exposure groups and nerve conduction velocities (NCVs) of each group were compared. The higher exposure group was the group whose mean cyclohexane exposure exceeded 100 ppm. The previous exposure data showed that cyclohexane vapour is almost exclusively an air contaminant and the exposures to other solvents-for example, toluene-and n-hexanewere much lower. The cyclohexane concentration in air ranged froth 13-720 ppm (tnedian 25-7 (12-8) 288(141.) Duration (ms) [1] [2] [3] [4] [5] [6] [7] [8] 
Pairs were matched at the time of the first study. we used it for its simplicity.
The following indices were used and are defined as:
(1) MNCV: maximum nerve conduction velocity of the motor fibres of the ulnar nerve between the wrist and elbow and common peroneal nerve between the knee and ankle.
(2) MDL: motor distal latency of the ulnar nerve and common peroneal nerve.
(3) SNCVp: proximal conduction velocity of sensory fibres of the ulnar nerve between the elbow and wrist.
(4) SNCVd: distal conduction velocity of sensory fibres of the ulnar nerve between the wrist and 5th metacarpophalangeal joint and the sural nerve between the calf and foot.
(5) Amplitude: amplitude of maximum sensory nerve action potential of the ulnar nerve and sural nerve.
(6) Duration: duration of sensory nerve action potential of the ulnar nerve and sural nerve.
The nerves were supramaximally stimulated with a single pulse of 0 1 ms (for motor nerves) or 0-2 ms (for sensory nerves) at a frequency of 2 Hz. The intensity of stimulation was 200-300 V (for motor nerves) or 50-150 V (for sensory nerves).
STATISTICAL CALCULATIONS Statistical analyses were carried out with Statview 4 0 procedures (Abacus Concepts).
The X2 test was used for comparing subjective symptoms. The paired t test was used for comparing the NCV variables between workers and age and sex matched controls and between the first and second studies. To compare the higher and lower exposure groups with the controls, analysis of variance (ANOVA) was performed followed by Scheffe's multiple comparison test." Multiple regression analysis (stepwise, backward) was done to consider the relation between exposure indices and NCV or motor distal latency (MDL), after adjustment for other confounding factors." Differences were considered significant at P < 5%. 16-3 (7-1) Duration (ms) 2-0 (0 4) 1-9 (0-4) 2-1 (0 3) *P < 0-05 v controls; **P < 0-01 v controls; tP < 0 05 2nd v 1st study; ftP < 0-01 v 2nd v 1st study.
One of the nine workers followed up had no history of exposure to n-hexane. Pairs were matched at the time of the first study.
Results

WORKING CONDITIONS AND EXPOSURE MEASUREMENTS
The individual external cyclohexane exposure ranged from five to 211 ppm, with a geometric mean (GM) of 28 ppm (GSD 22-35 ppm).
The individual cyclohexane exposure measured in the winter, six months before the first study, ranged from six to 720 ppm with a GM of 77 ppm (GSD 63-95 ppm). No improvement in equipment of the factory was made between that measurement and the present study, which was performed in hot weather in July and ventilation was better than in the winter because of open windows and many electric fans in the worksite. The urinary cyclohexanol concentration ranged from 0-12 to 8-23 mg/l, with a GM of 0 55 mg/l (GSD 045-068 mg/l).
SUBJECTIVE SYMPTOMS
There was no significant difference in subjective symptoms between workers exposed to solvent and matched controls. General fatigue was mentioned by nine of 18 workers exposed to cyclohexane and four of 15 controls (P < 0 1). Headache and dizziness were complained of by 10/18 and seven of 18 workers, and seven of 15 and four of 15 controls, respectively. An uneasy feeling was complained of by eight of 18 workers and five of 15 controls. For other chronic symptoms, there were smaller differences between workers and controls.
NEUROPHYSIOLOGICAL FINDINGS
The mean (SD, range) skin temperature was 32-4 (1) (2) (3) (4) (5) (6) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) in the arm and 31-8 (1 9, 26-34) in the leg. Table 2 shows the means (SDs) of NCVs among cyclohexane workers and matched controls. These NCVs were measurements of the last study for each worker. There were no significant differences in MNCVs and SNCVs between 18 exposed workers and age and sex matched controls. The ulnar and peroneal MDLs were significantly shorter in workers than in controls (P < 0-05). Analysis of variance among different exposure levels did not show significant differences in any neurophysiological variables. The mean exposures of the higher exposure group ranged from 126 to 384 ppm (median 156 ppm), and those of the lower exposure group ranged from 10 to 68 ppm (median 51 ppm, table 3). The ages, heights, and skin temperatures of all the groups were not significantly different. Table 4 shows the summary of the results of multiple regression analysis. Eighteen workers exposed to cyclohexane and 18 age and sex matched controls were included in the analysis. Dependent variables were neurophysiological indices, and independent variables were age, height, weight, body mass index, cigarette consumption, skin temperature, exposure duration, and individual mean exposure to cyclohexane, and duration of exposure to n-hexane. Alcohol consumption (ethanol equivalent ml/week) was not included in the analysis because of the multicollinearity between duration of exposure to n-hexane and alcohol consumption. Duration of exposure to cyclohexane had a significant negative relation with ulnar MDL (P < 0 05). Individual mean exposure to cyclohexane, mean value of the present and past exposure data, did not have significant relations with any of the neurophysiological indices. Table 5 shows the results of the follow up study on nine workers. The MNCV and SNCV of the legs were significantly improved in the second study compared with the first study (P < 0-01, P < 0-05) and MDLs of the arms and legs were significantly shortened in the second study (P < 0-05). Comparison of the results of the second study with the measurements for age and sex matched controls (n = 9), showed that MDLs of workers in the second study had significantly better conduction.
Discussion
As the main result, measurements of NCV did not show obvious or subclinical polyneuropathy under almost exclusive exposure to cyclohexane, the personal concentration of which ranged from 5 to 211 ppm (median 46 ppm).
An experimental study in rats showed no pathological changes in the tibial nerve, optical nerve, and medulla oblongata under the 2500 ppm, 30-week exposure to cyclohexane. This supports the validity of our study. On the other hand paralysis or neuropathological changes under exposure to cyclohexane were reported in humans and chickens.56 In those studies the exposure to cyclohexane was mixed with that to other solvents and the cyclohexane content of those solvents was less than 20%. The airborne concentration of cyclohexane was also low, less than 10 ppm.6 Whether the neuropathy is attributable to cyclohexane or not, further research is called for. Mutti reported a dose-dependent relation between the exposure of mixed solvents (nhexane, cyclohexane, methyl ethyl ketone) and subclinical neurophysiological changes. '2 Although the mean exposure to cyclohexane was over 70 ppm, the concentration of nhexane was also over 60 ppm. The effect of exposure to n-hexane could not be negligible. The exposure of the present study was lower than the time weighted average environmental limit in the United States and Japan," 300 ppm and 150 ppm, respectively.
The improvement of NCVs in the follow up study was considered to be due to past exposure to n-hexane. Chang reported delayed MNCV of the arms and legs in workers not exposed to n-hexane for four years.'4 Delayed worsening of MNCV was also found in five of 11 workers five to 10 months after the end of exposure to n-hexane. '4 In the present study 12 workers had a history of exposure to nhexane. The interval between the end of exposure to n-hexane and investigation was 0 3-2-6 years, with a mean (SD) of 1 2 (0 7) years in the first study. Therefore the first study was considered to have occurred during the recovery from subclinical neuropathy caused by nhexane.
Although the level of exposure to n-hexane which induces delay of NCVs was said to be more than 100 ppm in some reports,'5"" a few studies reported that the delay of NCV was caused by less than 100 ppm of n-hexane.'920 According to the health checks, the mean urinary concentration of 2,5-hexanedione was 9 03 (4-44) mg/l in winter and 2A4 (1-7) mg/l in summer, and 9 03 mg/l urinary 2,5-hexanedione was equivalent to 87-8 ppm of n-hexane as determined by Perbellini et al.21 Thus, we consider it was possible for past exposure to nhexane to cause neurophysiological changes and that the results of the first study were affected by past exposure to n-hexane.
No neurophysiological indices were impaired at the second study. This agreed with a report describing the prognosis of n-hexane neuropathy to be good. '4 Height, weight, body mass index, skin temperature, and cigarette consumption had independent significant relations with NCVs by multiple regression analysis in the present study. To detect effects of organic solvents on neurophysiological indices, these factors should be controlled as confounders. Skin temperature had significant relations with some neurophysiological indices, and improved nerve conduction in our study. Significantly positive relations between skin temperature and nerve conduction velocity were described in some previous studies.22' Differences in skin temperature between exposed workers and controls, however, were not significant. There are few reports on the relation between body build (height, weight, and BMI) and NCV other than in the median nerve. Takano et al, 24 Rivner et al, and Letz and Gerr reported a significant negative relation between height and NCV."2 In our study, height had a significantly negative relation with ulnar MNCV as well (table 5) and exposed workers were significantly shorter than matched controls (P < 0-01). Ulnar MNCV could be slower in exposed workers than in controls if there was no difference in height between them. Studies that reported a significant relation between cigarette consumption and NCVs could not been found.
The urinary cyclohexanol concentration was referred to as a good index of exposure to cyclohexane by the study,7 which was performed in the same factory on 33 workers at the time of our first investigation. In particular urinary cyclohexanol measured by an enzymatic method corrected for specific gravity and creatinine had a significant positive relation with airborne cyclohexane. We examined the relation only in workers recruited for the neurophysiological study, but adding the data of the first and the follow up study we found the same results (regression coefficient 0-8, P < 0000 1).
In conclusion, no evidence of neurotoxic effects was found when almost the only occupational exposure was to cyclohexane for a relatively short time and at low concentrations (below the time weighted average threshold limit value of the United States 
